Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
Assessment of Safety and Toxicity Among Infants Born to HIV-1-Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
A observational or N/A phase clinical study on HIV Infections, this trial is completed. The trial is conducted by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections and has accumulated 12 data snapshots since 2006. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2024 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Jun 2024 [monthly]
Completed
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jun 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bangkok, Thailand , Bangkok Noi, Thailand , Blantyre, Malawi , Chang Mai, Thailand , Chennai, India , Chiang Mai, Thailand , Gaborone, Botswana , Harare, Zimbabwe , Johannesburg, South Africa , Lilongwe, Malawi and 7 more locations